Product Information
BENZTROPINE MES 2 MG TABLET is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.0906 per EA under NDC 70752012511. Its NADAC has been published 43 times since Dec 10, 2025.
FDA first approved this application on Feb 11, 2025. Its Orange Book therapeutic-equivalence code is AA.
Strength
2 mg/1
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752012511
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZTROPINE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212694FDA Approved
2/11/2025
TE Code
AA
On Market Since
8/11/2025
Pharmacological Classes
Price Statistics
The NADAC for BENZTROPINE MES 2 MG TABLET has been published 43 times since Dec 10, 2025, and over the history we have for it it has declined 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0906 per EA |
|---|---|
| All-time high | $0.0992 (Dec 10, 2025) |
| All-time low | $0.0906 (Sep 23, 2026) |
| 52-week high | $0.0992 |
| 52-week low | $0.0906 |
| Median price | $0.0945 |
| Average price | $0.0942 |
| Largest weekly change | -2.8% (Feb 18, 2026) |
| Weeks tracked | 43 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BENZTROPINE MESYLATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZTROPINE MES 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENZTROPINE MES 2 MG TABLET, manufactured by Quagen Pharmaceuticals LLC, is $0.0906 per EA (NDC 70752012511), effective Sep 30, 2026.
How has the price of BENZTROPINE MES 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENZTROPINE MES 2 MG TABLET has declined 8.7%. It has been tracked across 43 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for BENZTROPINE MES 2 MG TABLET?
Since Dec 10, 2025, the NADAC for BENZTROPINE MES 2 MG TABLET has ranged from a low of $0.0906 (Sep 23, 2026) to a high of $0.0992 (Dec 10, 2025), with a median of $0.0945 per EA.
Are there cheaper alternatives to BENZTROPINE MES 2 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENZTROPINE MES 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BENZTROPINE MES 2 MG TABLET?
BENZTROPINE MES 2 MG TABLET (NDC 70752012511) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.